This timely adjustment reduces dropout rates and minimizes the emotional fatigue associated with repeated treatment disappointment, supporting better continuity and overall success
Dosage adjustments may be necessary to optimize results and minimize side effects like nausea or digestive discomfort
MASLD affects an estimated 30% of the global adult population, and currently has very limited treatment options
Other comparisons worth exploring include phentermine vs semaglutide for researchers evaluating traditional appetite suppressants against GLP-1 compounds, and sermorelin vs semaglutide for those interested in growth hormone secretagogue pathways
Participants receive regular clinical assessments, laboratory monitoring (including liver function, renal function, lipase levels, and thyroid function where indicated), and structured follow-up
Studies show that semaglutide can reduce major cardiovascular events by 26% in patients with type 2 diabetes